Meet EpiQMAx at the European Business Development Conference 2019

The event takes place from the 25th-26th of September 2019 in Heidelberg. More info here.

Meet EpiQMAx at the 4th Annual Epigenetics Forum 2019

The event takes place from the 3rd-4th of October 2019 in London. More info here.

Meet EpiQMAx at Meetup on December 10th 2019

We will talk about Epigenetics and how our service enables the pharmaceutical industry to decode the association of epigenetic modifications and diseases. Take part by signing up here.

EpiQMAx has been listed as an "Invest" company by the German Ministry of Economics

By investing on EpiQMAx, business angels could get back from the state a maximum of 20% their investment. More here.

EpiQMAx passes to the second phase of the Munich Business Plan contest

Our business idea keeps on convincing juries and the general public. In the 2019 competition of the Munich Business Plan, EpiQMAx was awarded a prize beside other 9 teams.

EpiQMAx GmbH is officially founded

We are happy to announce that as from October 19th 2018, EpiQMAx starts its bussines activity as a private Limited Liability Company.

EpiQMAx obtains funds from the EXIST Program

The EXIST scholarship for start-up founders is helping EpiQMAx in the implementation of its business idea and the realization of milestones important for our service.

EpiQMAx wins prize at MIT:FUTURA

Moritz presented our business idea at the MIT:FUTURA digital event in Berlin in June 2018. EpiQMAx was prized with the first place for its innovative business model and digital transformation strategy.

EpiQMAx is developing a KIT to measure protein modifications

We are developing a KIT to measure histone modifcations easily, reproducibly and fast. The first prototypes showed a greater yield and low losses of sample material. This means that we can achieve good levels of detection and quantification with low sample inputs. We aim now for a protective right and will work together with other experts in the field of proteomic KITs to achieve this.

EpiQMAx obtains funds from the FLÜGGE Program

For the month of September 2018, EpiQMAx will be supported by Flügge for, among other aspects, the development of a laboratory KIT.